1
|
Garattini L, Freemantle N. Comment on: 'Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition'. APPLIED HEALTH ECONOMICS AND HEALTH POLICY 2020; 18:453-454. [PMID: 32016830 DOI: 10.1007/s40258-020-00552-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Affiliation(s)
- Livio Garattini
- Centre for Health Economics, Institute for Pharmacological Research Mario Negri IRCCS, Ranica, Italy.
| | - Nick Freemantle
- Institute of Clinical Trials and Methodology, University College London, London, UK
| |
Collapse
|
2
|
Abbasi K. The fall and rise of the NHS. J R Soc Med 2017; 110:387. [PMID: 29043900 DOI: 10.1177/0141076817735234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|